Singapore’s Export Woes: Navigating Tariffs and Forecast Adjustments
Singapore's non-oil domestic exports fell by 4.6% in July 2025, with pharmaceuticals heavily impacting the decline. Analysts had predicted a 1.8% drop. Despite a free-trade agreement with the U.S., exports face a 10% tariff. Authorities caution that growth may slow as production adjustments to evade tariffs come to an end.

- Country:
- Singapore
Data released on Monday shows Singapore's non-oil domestic exports fell by 4.6% in July, contrary to analysts' predictions of a 1.8% annual decline. Pharmaceuticals were a major factor in the decrease, raising concerns over Singapore's trade outlook as exports to key markets such as the U.S. and China declined.
This downturn in exports comes despite the Singaporean economy outperforming expectations in the first half of 2025, prompting the government to adjust its full-year growth forecast to 1.5% to 2.5%. However, concerns linger due to a 10% tariff imposed by the U.S., challenging Singapore's trade relations even under a free-trade agreement.
Prime Minister Lawrence Wong expressed his concerns during the national day rally, indicating uncertainty over potential future tariff hikes on specific sectors like pharmaceuticals and semiconductors. Authorities remain cautious, projecting export growth of 1% to 3% for the year while warning of possible vulnerability in the latter half of 2025.
(With inputs from agencies.)
ALSO READ
Europe's Science Independence: A Shift from U.S. Reliance
How Climate Adaptation Can Save Peru’s Economy from El Niño and Rising Temperatures
U.S. Women's Relay Team Sets New World Record in Medley
Canadian-U.S. Trade Tensions: Fentanyl and Tariff Talks
Economic Recovery Hopes Boost Asian Markets Despite U.S. Policy Concerns